Seattle Biotech Startup Curi Bio Raises $10M Led by DreamCIS to Advance 3D Tissue Drug Discovery Platforms
Seattle biotech startup Curi Bio raised $10 million in Series B funding led by DreamCIS to expand its R&D platform using 3D tissue models for drug discovery. The company serves major pharmaceutical firms and aims to develop new platforms for various muscle and metabolic diseases.
Curi Bio raises $10M Series A to advance Mantarry stem cell drug-discovery platform
Seattle startup Curi Bio raised $10 million in Series A to advance its Mantarry stem cell-focused drug discovery platform and expand the business.
Organizations
-
Curi Bio Chief Strategy Officer · current